PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30108796-2 2017 Herein, we report the first toxicological evaluation of imidazopyridine-based DGAT2 inhibitors and show that the arteriopathy associated with imidazopyridine 1 can be mitigated with small structural modifications, and is thus not mechanism related. imidazopyridine 56-71 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 78-83 30422629-5 2018 Herein, we describe imidazopyridines represented by PF-06424439 (1) and 2 as long residence time inhibitors of DGAT2. imidazopyridine 20-36 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 111-116 30422629-9 2018 A binding assay utilizing 125I-labeled imidazopyridine demonstrated that the level of imidazopyridine binding to DGAT2 mutant enzymes, H161A and H163A, dramatically decreased to 11-17% of that of the wild-type enzyme, indicating that these residues are critical for imidazopyridines to bind to DGAT2. imidazopyridine 39-54 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 113-118 30422629-9 2018 A binding assay utilizing 125I-labeled imidazopyridine demonstrated that the level of imidazopyridine binding to DGAT2 mutant enzymes, H161A and H163A, dramatically decreased to 11-17% of that of the wild-type enzyme, indicating that these residues are critical for imidazopyridines to bind to DGAT2. imidazopyridine 86-101 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 113-118 30422629-9 2018 A binding assay utilizing 125I-labeled imidazopyridine demonstrated that the level of imidazopyridine binding to DGAT2 mutant enzymes, H161A and H163A, dramatically decreased to 11-17% of that of the wild-type enzyme, indicating that these residues are critical for imidazopyridines to bind to DGAT2. imidazopyridine 86-101 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 294-299 30422629-9 2018 A binding assay utilizing 125I-labeled imidazopyridine demonstrated that the level of imidazopyridine binding to DGAT2 mutant enzymes, H161A and H163A, dramatically decreased to 11-17% of that of the wild-type enzyme, indicating that these residues are critical for imidazopyridines to bind to DGAT2. imidazopyridine 266-282 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 113-118 30422629-10 2018 Taken together, imidazopyridines may thus represent a promising lead series for the development of DGAT2 inhibitors that display an unprecedented combination of potency, selectivity, and in vivo efficacy. imidazopyridine 16-32 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 99-104 26349027-0 2015 Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2). imidazopyridine 30-45 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 66-98 26349027-0 2015 Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2). imidazopyridine 30-45 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 100-105 26349027-1 2015 The medicinal chemistry and preclinical biology of imidazopyridine-based inhibitors of diacylglycerol acyltransferase 2 (DGAT2) is described. imidazopyridine 51-66 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 87-119 26349027-1 2015 The medicinal chemistry and preclinical biology of imidazopyridine-based inhibitors of diacylglycerol acyltransferase 2 (DGAT2) is described. imidazopyridine 51-66 acyl-CoA wax alcohol acyltransferase 1 Homo sapiens 121-126